Evidence map›Paper›PMID 26684017›Full record

ReviewMedical principles and practice : international journal of the Kuwait University, Health Science Centre

Antimicrobial Peptides as Anti-Infectives against Staphylococcus epidermidis.

Sangya Agarwal, Garima Sharma, Shweta Dang, Sanjay Gupta, Reema Gabrani

Abstract readReview
In one paragraph

Review in Medical principles and practice : international journal of the Kuwait University, Health Science Centre. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. The Evolution of Symbiosis inBiomolecules · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Effect of Camel Peptide on the Biofilm ofAntibiotics (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Oreoch-1: A Peptide fromPathogens (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Antibacterial Activity, Cytotoxicity, and the Mechanism of Action of Bacteriocin from Bacillus subtilis GAS101.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sangya AgarwalDepartment of Biotechnology, Jaypee Institute of Information Technology, Noida, India.
Garima Sharma
Shweta Dang
Sanjay Gupta
Reema Gabrani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus epidermidis has emerged as the main causative agent for graft-related and nosocomial infections. Rampant use of antibiotics and biofilm formed by the organism results in poor penetration of the drug and further aggravates the antibiotic resistance, emphasizing an urgent need to explore alternative treatment modalities. Antimicrobial peptides (AMPs), produced as effector molecules of the innate immunity of living organisms, have therapeutic potential that can be used to inhibit the growth of microbes. In addition, the susceptibility of a microbe to become resistant to an AMP is relatively low. The AMPs are amphipathic peptides of 12-100 residues, which have broad-spectrum activity against microbes. There are scattered reports of AMPs listed against S. epidermidis and there is an urgent need to systematically study the AMPs. Various natural AMPs as well as synthetic peptides have been investigated against S. epidermidis. These peptides have been shown to inhibit both planktonic culture and S. epidermidis biofilm effectively. The multiple modes of action in killing the organism minimize the chances for the development of resistance. This review focused on various natural and synthetic peptides that demonstrate activity against S. epidermidis.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBacteriocinsBiofilmsDrug DesignHumansOligopeptidesPeptides, CyclicProteinsStaphylococcus epidermidisAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacteriocinsbuforin IIepidermicin NI01, Staphylococcus epidermidisJelleine IJelleine IIJelleine IIIOligopeptidesPeptides, CyclicProteinsranalexin

Identifiers

PMID26684017
PMCPMC5588407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.